{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T06:09:41Z","timestamp":1790057381801,"version":"4.0.1"},"reference-count":44,"publisher":"The Company of Biologists","issue":"21","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,11,1]]},"abstract":"<jats:p>Overexpression of C-natriuretic peptide (CNP) in cartilage partially rescues achondroplasia in the mouse. Here, we studied the interaction of fibroblast growth factor (FGF) and CNP signaling in chondrocytes. CNP antagonized FGF2-induced growth arrest of rat chondrosarcoma (RCS) chondrocytes by inhibition of the Erk mitogen activated protein kinase pathway. This effect of CNP was protein kinase G-dependent and was mimicked by the cGMP analog pCPT-cGMP. FGF2-mediated activation of both MEK and Raf-1 but not Ras or FRS2 was abolished by CNP demonstrating that CNP blocks the Erk pathway at the level of Raf-1. CNP also counteracted the FGF2-mediated degradation of RCS extracellular matrix. CNP partially antagonized FGF2-induced expression, release and activation of several matrix-remodeling molecules including matrix metalloproteinase 2 (MMP2), MMP3, MMP9, MMP10 and MMP13. In addition, CNP compensated for FGF2-mediated matrix loss by upregulation of matrix production independent of its interference with FGF signaling. We conclude that CNP utilizes both direct and indirect ways to counteract the effects of FGF signaling in a chondrocyte environment.<\/jats:p>","DOI":"10.1242\/jcs.02618","type":"journal-article","created":{"date-parts":[[2005,10,19]],"date-time":"2005-10-19T03:38:43Z","timestamp":1129693123000},"page":"5089-5100","source":"Crossref","is-referenced-by-count":149,"title":["Interaction of fibroblast growth factor and C-natriuretic peptide signaling in regulation of chondrocyte proliferation and extracellular matrix homeostasis"],"prefix":"10.1242","volume":"118","author":[{"given":"Pavel","family":"Krejci","sequence":"first","affiliation":[{"name":"Medical Genetics Institute, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Masri","sequence":"additional","affiliation":[{"name":"INSERM U589, Institut Louis Bugnard, 31403 Toulouse, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Fontaine","sequence":"additional","affiliation":[{"name":"INSERM U589, Institut Louis Bugnard, 31403 Toulouse, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pertchoui B.","family":"Mekikian","sequence":"additional","affiliation":[{"name":"Medical Genetics Institute, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MaryAnn","family":"Weis","sequence":"additional","affiliation":[{"name":"Orthopaedic Research Laboratories, University of Washington, Seattle, WA 98195, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herve","family":"Prats","sequence":"additional","affiliation":[{"name":"INSERM U589, Institut Louis Bugnard, 31403 Toulouse, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William R.","family":"Wilcox","sequence":"additional","affiliation":[{"name":"Medical Genetics Institute, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA"},{"name":"Department of Pediatrics, UCLA School of Medicine, CA 90095, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"237","reference":[{"key":"2021042519072655300_REF1","doi-asserted-by":"crossref","unstructured":"Aikawa, T., Segre, G. V. and Lee, K. (2001). Fibroblast growth factor inhibits chondrocytic growth through induction of p21 and subsequent inactivation of cyclin E-Cdk2. J. Biol. Chem.276, 29347-29352.","DOI":"10.1074\/jbc.M101859200"},{"key":"2021042519072655300_REF2","doi-asserted-by":"crossref","unstructured":"Bartels, C. F., Bu\u0308ku\u0308lmez, H., Padayatti, P., Rhee, D. K., van Ravenswaaij-Arts, C., Pauli, R. M., Mundlos, S., Chitayat, D., Shih, L. Y., Al-Gazali, L. I. et al. (2004). Mutations in the transmembrane natriuretic peptide receptor NPR-B impair skeletal growth and cause acromesomelic dysplasia, type Maroteaux. Am. J. Hum. Genet.75, 27-34.","DOI":"10.1086\/422013"},{"key":"2021042519072655300_REF3","doi-asserted-by":"crossref","unstructured":"Chusho, H., Tamura, N., Ogawa, Y., Yasoda, A., Suda, M., Miyazawa, T., Nakamura, K., Nakao, K., Kurihara, T., Komatsu, Y. et al. (2001). Dwarfism and early death in mice lacking C-type natriuretic peptide. Proc. Natl. Acad. Sci. USA98, 4016-4021.","DOI":"10.1073\/pnas.071389098"},{"key":"2021042519072655300_REF4","doi-asserted-by":"crossref","unstructured":"Dhillon, A. S. and Kolch, W. (2002). Untying the regulation of the Raf-1 kinase. Arch. Biochem. Biophys.404, 3-9.","DOI":"10.1016\/S0003-9861(02)00244-8"},{"key":"2021042519072655300_","doi-asserted-by":"crossref","unstructured":"Dousa, T. P. (1999). Cyclic-3\u2032,5\u2032-nucleotide phosphodiesterase isozymes in cell biology and pathophysiology of the kidney. Kidney Int.55, 29-62.","DOI":"10.1046\/j.1523-1755.1999.00233.x"},{"key":"2021042519072655300_","doi-asserted-by":"crossref","unstructured":"Drewett, J. G. and Garbers, D. L. (1994). The family of guanylyl cyclase receptors and their ligands. Endocr. Rev.15, 135-162.","DOI":"10.1210\/edrv-15-2-135"},{"key":"2021042519072655300_REF7","doi-asserted-by":"crossref","unstructured":"Fosang, A. J., Neame, P. J., Hardingham, T. E., Murphy, G. and Hamilton, J. A. (1991). Cleavage of cartilage proteoglycan between G1 and G2 domains by stromelysins. J. Biol. Chem.266, 15579-15582.","DOI":"10.1016\/S0021-9258(18)98442-5"},{"key":"2021042519072655300_REF8","doi-asserted-by":"crossref","unstructured":"Fosang, A. J., Neame, P. J., Last, K., Hardingham, T. E., Murphy, G. and Hamilton, J. A. (1992). The interglobular domain of cartilage aggrecan is cleaved by PUMP, gelatinases, and cathepsin B. J. Biol. Chem.267, 19470-19474.","DOI":"10.1016\/S0021-9258(18)41799-1"},{"key":"2021042519072655300_REF9","doi-asserted-by":"crossref","unstructured":"Hagiwara, H., Sakaguchi, H., Itakura, M., Yoshimoto, T., Furuya, M., Tanaka, S. and Hirose, S. (1994). Autocrine regulation of rat chondrocyte proliferation by natriuretic peptide C and its receptor, natriuretic peptide receptor-B. J. Biol. Chem.269, 10729-10733.","DOI":"10.1016\/S0021-9258(17)34119-4"},{"key":"2021042519072655300_REF10","doi-asserted-by":"crossref","unstructured":"Han, S., Sidell, N. and Roman, J. (2005). Fibronectin stimulates human lung carcinoma cell proliferation by suppressing p21 gene expression via signals involving Erk and Rho kinase. Cancer Lett.219, 71-81.","DOI":"10.1016\/j.canlet.2004.07.040"},{"key":"2021042519072655300_REF11","doi-asserted-by":"crossref","unstructured":"Henderson, J. E., Naski, M. C., Aarts, M. M., Wang, D., Cheng, L., Goltzman, D. and Ornitz, D. M. (2000). Expression of FGFR3 with the G380R achondroplasia mutation inhibits proliferation and maturation of CFK2 chondrocytic cells. J. Bone Miner. Res.15, 155-165.","DOI":"10.1359\/jbmr.2000.15.1.155"},{"key":"2021042519072655300_REF12","doi-asserted-by":"crossref","unstructured":"Kase, H., Iwahashi, K., Nakanishi, S., Matsuda, Y., Yamada, K., Takahashi, M., Murakata, C., Sato, A. and Kaneko, M. (1987). K-252 compounds novel and potent inhibitors of protein kinase C and cyclic nucleotide-dependent protein kinases. Biochem. Biophys. Res. Commun.142, 436-440.","DOI":"10.1016\/0006-291X(87)90293-2"},{"key":"2021042519072655300_","doi-asserted-by":"crossref","unstructured":"Koller, K. J. and Goeddel, D. V. (1992). Molecular biology of the natriuretic peptides and their receptors. Circulation86, 1081-1088.","DOI":"10.1161\/01.CIR.86.4.1081"},{"key":"2021042519072655300_REF14","doi-asserted-by":"crossref","unstructured":"Kouhara, H., Hadari, Y. R., Spivak-Kroizman, T., Schilling, J., Bar-Sagi, D., Lax, I. and Schlessinger, J. (1997). A lipid-anchored Grb2-binding protein that links FGF-receptor activation to the Ras\/MAPK signaling pathway. Cell89, 693-702.","DOI":"10.1016\/S0092-8674(00)80252-4"},{"key":"2021042519072655300_REF15","doi-asserted-by":"crossref","unstructured":"Krejci, P., Bryja, V., Pachernik, J., Hampl, A., Pogue, R., Mekikian, P. and Wilcox, W. R. (2004). FGF2 inhibits proliferation and alters the cartilage-like phenotype of RCS cells. Exp. Cell Res.297, 152-164.","DOI":"10.1016\/j.yexcr.2004.03.011"},{"key":"2021042519072655300_REF16","doi-asserted-by":"crossref","unstructured":"Lax, I., Wong, A., Lamothe, B., Lee, A., Frost, A., Hawes, J. and Schlessinger, J. (2002). The docking protein FRS2alpha controls a MAP kinase-mediated negative feedback mechanism for signaling by FGF receptors. Mol. Cell10, 709-719.","DOI":"10.1016\/S1097-2765(02)00689-5"},{"key":"2021042519072655300_REF17","doi-asserted-by":"crossref","unstructured":"Legeai-Mallet, L., Benoist-Lasselin, C., Munnich, A. and Bonaventure, J. (2004). Overexpression of FGFR3, Stat1, Stat5 and p21Cip1 correlates with phenotypic severity and defective chondrocyte differentiation in FGFR3-related chondrodysplasias. Bone34, 26-36.","DOI":"10.1016\/j.bone.2003.09.002"},{"key":"2021042519072655300_REF18","doi-asserted-by":"crossref","unstructured":"Li, C., Chen, L., Iwata, T., Kitagawa, M., Fu, X. Y. and Deng, C. X. (1999). A Lys644Glu substitution in fibroblast growth factor receptor 3 (FGFR3) causes dwarfism in mice by activation of STATs and ink4 cell cycle inhibitors. Hum. Mol. Genet.8, 35-44.","DOI":"10.1093\/hmg\/8.1.35"},{"key":"2021042519072655300_REF19","doi-asserted-by":"crossref","unstructured":"Little, C. B., Hughes, C. E., Curtis, C. L., Janusz, M. J., Bohne, R., Wang-Weigand, S., Taiwo, Y. O., Mitchell, P. G., Otterness, I. G., Flannery, C. R. et al. (2002). Matrix metalloproteinases are involved in C-terminal and interglobular domain processing of cartilage aggrecan in late stage cartilage degradation. Matrix Biol.21, 271-288.","DOI":"10.1016\/S0945-053X(02)00004-5"},{"key":"2021042519072655300_REF20","doi-asserted-by":"crossref","unstructured":"Lucas, K. A., Pitari, G. M., Kazerounian, S., Ruiz-Stewart, I., Park, J., Schulz, S., Chepenik, K. P. and Waldman, S. A. (2000). Guanylyl cyclases and signaling by cyclic GMP. Pharmacol. Rev.52, 375-414.","DOI":"10.1016\/S0031-6997(24)01457-1"},{"key":"2021042519072655300_REF21","doi-asserted-by":"crossref","unstructured":"Marshak, D. R., Lukas, T. J. and Watterson, D. M. (1985). Drug-protein interactions: binding of chlorpromazine to calmodulin, calmodulin fragments, and related calcium binding proteins. Biochemistry24, 144-150.","DOI":"10.1021\/bi00322a020"},{"key":"2021042519072655300_REF22","doi-asserted-by":"crossref","unstructured":"Mericq, V., Uyeda, J. A., Barnes, K. M., De Luca, F. and Baron, J. (2000). Regulation of fetal rat bone growth by C-type natriuretic peptide and cGMP. Pediatr. Res.47, 189-193.","DOI":"10.1203\/00006450-200002000-00007"},{"key":"2021042519072655300_REF23","doi-asserted-by":"crossref","unstructured":"Miller, J. P., Boswell, K. H., Muneyama, K., Simon, L. N., Robins, R. K. and Shuman, D. A. (1973). Synthesis and biochemical studies of various 8-substituted derivatives of guanosine 3\u2032,5\u2032-cyclic phosphate, inosine 3\u2032,5\u2032-cyclic phosphate, and xanthosine 3\u2032,5\u2032-cyclic phosphate. Biochemistry12, 5310-5319.","DOI":"10.1021\/bi00750a014"},{"key":"2021042519072655300_REF24","doi-asserted-by":"crossref","unstructured":"Miyazawa, T., Ogawa, Y., Chusho, H., Yasoda, A., Tamura, N., Komatsu, Y., Pfeifer, A., Hofmann, F. and Nakao, K. (2002). Cyclic GMP-dependent protein kinase II plays a critical role in C-type natriuretic peptide-mediated endochondral ossification. Endocrinology143, 3604-3610.","DOI":"10.1210\/en.2002-220307"},{"key":"2021042519072655300_REF25","unstructured":"Mukoyama, M., Nakao, K., Hosoda, K., Suga, S., Saito, Y., Ogawa, Y., Shirakami, G., Jougasaki, M., Obata, K., Yasue, H. et al. (1991). Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide. J. Clin. Invest.87, 1402-1412."},{"key":"2021042519072655300_REF26","doi-asserted-by":"crossref","unstructured":"Murakami, S., Balmes, G., McKinney, S., Zhang, Z., Givol, D. and de Crombrugghe, B. (2004). Constitutive activation of MEK1 in chondrocytes causes Stat1-independent achondroplasia-like dwarfism and rescues the Fgfr3-deficient mouse phenotype. Genes Dev.18, 290-305.","DOI":"10.1101\/gad.1179104"},{"key":"2021042519072655300_REF27","doi-asserted-by":"crossref","unstructured":"Nakamura, H., Fujii, Y., Ohuchi, E., Yamamoto, E. and Okada, Y. (1998). Activation of the precursor of human stromelysin 2 and its interactions with other matrix metalloproteinases. Eur. J. Biochem.253, 67-75.","DOI":"10.1046\/j.1432-1327.1998.2530067.x"},{"key":"2021042519072655300_REF28","doi-asserted-by":"crossref","unstructured":"Okada, A., Tomasetto, C., Lutz, Y., Bellocq, J. P., Rio, M. C. and Basset, P. (1997). Expression of matrix metalloproteinases during rat skin wound healing: evidence that membrane type-1 matrix metalloproteinase is a stromal activator of pro-gelatinase A. J. Cell Biol.,137, 67-77.","DOI":"10.1083\/jcb.137.1.67"},{"key":"2021042519072655300_REF29","doi-asserted-by":"crossref","unstructured":"Pages, G., Lenormand, P., L'Allemain, G., Chambard, J. C., Meloche, S., Pouyssegur, J. (1993). Mitogen-activated protein kinases p42mapk and p44mapk are required for fibroblast proliferation. Proc. Natl. Acad. Sci. USA90, 8319-8323.","DOI":"10.1073\/pnas.90.18.8319"},{"key":"2021042519072655300_REF30","doi-asserted-by":"crossref","unstructured":"Passos-Bueno, M. R., Wilcox, W. R., Jabs, E. W., Sertie, A. L., Alonso, L. G. and Kitoh, H. (1999). Clinical spectrum of fibroblast growth factor receptor mutations. Hum. Mutat.14, 115-125.","DOI":"10.1002\/(SICI)1098-1004(1999)14:2<115::AID-HUMU3>3.0.CO;2-2"},{"key":"2021042519072655300_REF31","doi-asserted-by":"crossref","unstructured":"Poulos, J. E., Weber, J. D., Bellezzo, J. M., Di Bisceglie, A. M., Britton, R. S., Bacon, B. R. and Baldassare, J. J. (1997). Fibronectin and cytokines increase JNK, ERK, AP-1 activity, and transin gene expression in rat hepatic stellate cells. Am. J. Physiol.273, G804-G811.","DOI":"10.1152\/ajpgi.1997.273.4.G804"},{"key":"2021042519072655300_REF32","doi-asserted-by":"crossref","unstructured":"Raucci, A., Laplantine, E., Mansukhani, A. and Basilico, C. (2004). Activation of the ERK1\/2 and p38 mitogen-activated protein kinase pathways mediates fibroblast growth factor-induced growth arrest of chondrocytes. J. Biol. Chem.279, 1747-1756.","DOI":"10.1074\/jbc.M310384200"},{"key":"2021042519072655300_REF33","doi-asserted-by":"crossref","unstructured":"Rosenzweig, A. and Seidman, C. (1991). Atrial natriuretic factor and related peptide hormones. Annu. Rev. Biochem.60, 229-255.","DOI":"10.1146\/annurev.bi.60.070191.001305"},{"key":"2021042519072655300_REF34","doi-asserted-by":"crossref","unstructured":"Silberbach, M. and Roberts, C. T., Jr (2001). Natriuretic peptide signalling: molecular and cellular pathways to growth regulation. Cell Signal. 13, 221-231.","DOI":"10.1016\/S0898-6568(01)00139-5"},{"key":"2021042519072655300_REF35","doi-asserted-by":"crossref","unstructured":"Sirotkin, A. V., Makarevich, A. V., Genieser, H. G., Kotwica, J., Hetenyi, L. (2000). Effect of four cGMP analogues with different mechanisms of action on hormone release by porcine ovarian granulosa cells in vitro. Exp. Clin. Endocrinol. Diabetes108, 214-219.","DOI":"10.1055\/s-2000-7745"},{"key":"2021042519072655300_REF36","doi-asserted-by":"crossref","unstructured":"Stickens, D., Behonick, D. J., Ortega, N., Heyer, B., Hartenstein, B., Yu, Y., Fosang, A. J., Schorpp-Kistner, M., Angel, P. and Werb, Z. (2004). Altered endochondral bone development in matrix metalloproteinase 13-deficient mice. Development131, 5883-5895.","DOI":"10.1242\/dev.01461"},{"key":"2021042519072655300_REF37","doi-asserted-by":"crossref","unstructured":"Suga, S., Nakao, K., Hosoda, K., Mukoyama, M., Ogawa, Y., Shirakami, G., Arai, H., Kambayashi, Y., Inouye, K. et al. (1992). Receptor selectivity of natriuretic peptide family, atrial natriuretic peptide, brain natriuretic peptide, and C-type natriuretic peptide. Endocrinology130, 229-239.","DOI":"10.1210\/endo.130.1.1309330"},{"key":"2021042519072655300_REF38","doi-asserted-by":"crossref","unstructured":"Suhasini, M., Li, H., Lohmann, S. M., Boss, G. R. and Pilz, R. B. (1998). Cyclic-GMP-dependent protein kinase inhibits the Ras\/Mitogen-activated protein kinase pathway. Mol. Cell. Biol.18, 6983-6994.","DOI":"10.1128\/MCB.18.12.6983"},{"key":"2021042519072655300_REF39","unstructured":"Takase, Y., Saeki, T., Watanabe, N., Adachi, H., Souda, S. and Saito, I. (1994). Cyclic GMP phosphodiesterase inhibitors. 2. Requirement of 6-substitution of quinazoline derivatives for potent and selective inhibitory activity. J. Med. Chem.37, 2106-2111."},{"key":"2021042519072655300_REF40","doi-asserted-by":"crossref","unstructured":"Tamura, N., Doolittle, L. K., Hammer, R. E., Shelton, J. M., Richardson, J. A. and Garbers, D. L. (2004). Critical roles of the guanylyl cyclase B receptor in endochondral ossification and development of female reproductive organs. Proc. Natl. Acad. Sci. USA101, 17300-17305.","DOI":"10.1073\/pnas.0407894101"},{"key":"2021042519072655300_REF41","doi-asserted-by":"crossref","unstructured":"Tsuji, T. and Kunieda, T. (2005). A loss-of-function mutation in natriuretic peptide receptor 2 (Npr2) gene is responsible for disproportionate dwarfism in cn\/cn mouse. J. Biol. Chem.280, 14288-14292.","DOI":"10.1074\/jbc.C500024200"},{"key":"2021042519072655300_REF42","doi-asserted-by":"crossref","unstructured":"Wilcox, W. R., Tavormina, P. L., Krakow, D., Kitoh, H., Lachman, R. S., Wasmuth, J. J., Thompson, L. M. and Rimoin, D. L. (1998). Molecular, radiologic, and histopathologic correlations in thanatophoric dysplasia. Am. J. Med. Genet.78, 274-281.","DOI":"10.1002\/(SICI)1096-8628(19980707)78:3<274::AID-AJMG14>3.0.CO;2-C"},{"key":"2021042519072655300_REF43","doi-asserted-by":"crossref","unstructured":"Yasoda, A., Ogawa, Y., Suda, M., Tamura, N., Mori, K., Sakuma, Y., Chusho, H., Shiota, K., Tanaka, K. and Nakao, K. (1998). Natriuretic peptide regulation of endochondral ossification. Evidence for possible roles of the C-type natriuretic peptide\/guanylyl cyclase-B pathway. J. Biol. Chem.273, 11695-11700.","DOI":"10.1074\/jbc.273.19.11695"},{"key":"2021042519072655300_REF44","doi-asserted-by":"crossref","unstructured":"Yasoda, A., Komatsu, Y., Chusho, H., Miyazawa, T., Ozasa, A., Miura, M., Kurihara, T., Rogi, T., Tanaka, S., Suda, M. et al. (2004). Overexpression of CNP in chondrocytes rescues achondroplasia through a MAPK-dependent pathway. Nat. Med.10, 80-86.","DOI":"10.1038\/nm971"}],"container-title":["Journal of Cell Science"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.biologists.com\/jcs\/article-pdf\/118\/21\/5089\/1367125\/5089.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/journals.biologists.com\/jcs\/article-pdf\/118\/21\/5089\/1367125\/5089.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,5]],"date-time":"2025-01-05T01:35:45Z","timestamp":1736040945000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.biologists.com\/jcs\/article\/118\/21\/5089\/28544\/Interaction-of-fibroblast-growth-factor-and-C"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,11,1]]},"references-count":44,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2005,11,1]]}},"URL":"https:\/\/doi.org\/10.1242\/jcs.02618","relation":{},"ISSN":["1477-9137","0021-9533"],"issn-type":[{"value":"1477-9137","type":"electronic"},{"value":"0021-9533","type":"print"}],"subject":[],"published":{"date-parts":[[2005,11,1]]}}}